Inclusion criteria |
1. Age is between 40–90 years old |
2. Weight is between 45–85 kg |
3. Acute exacerbation of COPD with clinical grade 1–2 that only requires ordinary hospitalization |
4. Syndrome differentiation as Fei_Shen_Qi_Yu_Re Zheng in TCM |
5. Voluntarily signed informed consent |
Exclusion criteria |
1. Patients who also have bronchial asthma, bronchiectasis, active tuberculosis, pulmonary fibrosis, pneumothorax, pleural effusion, pulmonary embolism, or neuromuscular disease affecting respiratory function |
2. Patients who also have leukemia, aplastic anemia, myelodysplastic syndrome, thrombocytopenia, multiple myeloma, or other blood diseases |
3. Patients who also have malignant tumors |
3. Patients who also have rheumatic immune diseases and adrenal insufficiency or patients requiring hormones or immunosuppressants |
4. Pregnant or planning to become pregnant or lactating women |
5. Severe impairment of heart, liver and kidney function (heart function 3–4 degree, aspartate aminotransferase (ALT) and/or alanine aminotransferase (AST) exceeds 1.5 times of the upper limit of normal, creatinine (Cr) exceeds the upper limit of normal) |
6. Received systemic glucocorticoids within 2 weeks or participation in other drug clinical trials within 3 months prior to the trial |
7. Other conditions that the investigators consider to be improper |